SEC Filings
Monopar Says $129.4 Million Can Fund Its Drug Push Through At Least March 2028
The funding estimate includes a potential Wilson disease drug launch as Monopar works to finish its FDA application.
Monopar Therapeutics (MNPR) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The funding estimate includes a potential Wilson disease drug launch as Monopar works to finish its FDA application.
SEC Filings
The asset manager's passive filing shows sole voting power over 330,149 shares of the cancer and Wilson disease drug developer.